Feb 3 (Reuters) - Drugmaker Bristol-Myers Squibb Co on Wednesday entered into an agreement with The Rockefeller University to globally develop, make and sell Rockefeller’s therapy in development to treat COVID-19.
Reporting by Trisha Roy in Bengaluru; Editing by Shinjini Ganguli
我们的标准: 汤森路透“信任原则”